These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 26213846)
1. NOP14 suppresses breast cancer progression by inhibiting NRIP1/Wnt/β-catenin pathway. Lei JJ; Peng RJ; Kuang BH; Yuan ZY; Qin T; Liu WS; Guo YM; Han HQ; Lian YF; Deng CC; Zhang HJ; Chen LZ; Feng QS; Xu M; Feng L; Bei JX; Zeng YX Oncotarget; 2015 Sep; 6(28):25701-14. PubMed ID: 26213846 [TBL] [Abstract][Full Text] [Related]
2. NOP14 regulates the growth, migration, and invasion of colorectal cancer cells by modulating the NRIP1/GSK-3β/β-catenin signaling pathway. Zhu X; Jia W; Yan Y; Huang Y; Wang B Eur J Histochem; 2021 Jul; 65(3):. PubMed ID: 34218653 [TBL] [Abstract][Full Text] [Related]
3. NOP14 inhibits melanoma proliferation and metastasis by regulating Wnt/β-catenin signaling pathway. Li J; Fang R; Wang J; Deng L Braz J Med Biol Res; 2018 Nov; 52(1):e7952. PubMed ID: 30484495 [TBL] [Abstract][Full Text] [Related]
4. The NOP14 nucleolar protein suppresses the function and stemness of melanoma stem-like cells through Wnt/beta-catenin signaling inactivation. Li J; Fang R; Wu J; Si Y; Bai J; Wang Q Bioengineered; 2022 Mar; 13(3):7648-7658. PubMed ID: 35282769 [TBL] [Abstract][Full Text] [Related]
5. Expression of XB130 in human ductal breast cancer. Li J; Sun W; Wei H; Wang X; Li H; Yi Z Int J Clin Exp Pathol; 2015; 8(5):5300-8. PubMed ID: 26191231 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis. Cai J; Guan H; Fang L; Yang Y; Zhu X; Yuan J; Wu J; Li M J Clin Invest; 2013 Feb; 123(2):566-79. PubMed ID: 23321667 [TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway. Kong LY; Xue M; Zhang QC; Su CF Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945 [TBL] [Abstract][Full Text] [Related]
8. Transducin (β)-like 1 X-linked receptor 1 promotes proliferation and tumorigenicity in human breast cancer via activation of beta-catenin signaling. Li X; Liang W; Liu J; Lin C; Wu S; Song L; Yuan Z Breast Cancer Res; 2014 Oct; 16(5):465. PubMed ID: 25341494 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression. Liu F; Liu Y; Shen J; Zhang G; Han J Oncotarget; 2016 Aug; 7(31):49130-49142. PubMed ID: 27323393 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer. Tan Z; Zheng H; Liu X; Zhang W; Zhu J; Wu G; Cao L; Song J; Wu S; Song L; Li J Oncotarget; 2016 Apr; 7(17):24076-87. PubMed ID: 26992223 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway. Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855 [TBL] [Abstract][Full Text] [Related]
12. DACT1, an antagonist to Wnt/β-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer. Yin X; Xiang T; Li L; Su X; Shu X; Luo X; Huang J; Yuan Y; Peng W; Oberst M; Kelly K; Ren G; Tao Q Breast Cancer Res; 2013 Mar; 15(2):R23. PubMed ID: 23497530 [TBL] [Abstract][Full Text] [Related]
13. Suppressing NRIP1 inhibits growth of breast cancer cells in vitro and in vivo. Aziz MH; Chen X; Zhang Q; DeFrain C; Osland J; Luo Y; Shi X; Yuan R Oncotarget; 2015 Nov; 6(37):39714-24. PubMed ID: 26492163 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway. Zheng K; Zhou X; Yu J; Li Q; Wang H; Li M; Shao Z; Zhang F; Luo Y; Shen Z; Chen F; Shi F; Cui C; Zhao D; Lin Z; Zheng W; Zou Z; Huang Z; Zhao L Cancer Lett; 2016 Jun; 376(1):178-87. PubMed ID: 27037061 [TBL] [Abstract][Full Text] [Related]
15. KDM3B-ETF1 fusion gene downregulates LMO2 via the WNT/β-catenin signaling pathway, promoting metastasis of invasive ductal carcinoma. Hu A; Hong F; Li D; Xie Q; Chen K; Zhu L; He H Cancer Gene Ther; 2022 Feb; 29(2):215-224. PubMed ID: 33828234 [TBL] [Abstract][Full Text] [Related]
16. miR-190 enhances endocrine therapy sensitivity by regulating SOX9 expression in breast cancer. Yu Y; Yin W; Yu ZH; Zhou YJ; Chi JR; Ge J; Cao XC J Exp Clin Cancer Res; 2019 Jan; 38(1):22. PubMed ID: 30658681 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway. Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584 [TBL] [Abstract][Full Text] [Related]
18. EYA4 functions as tumor suppressor gene and prognostic marker in pancreatic ductal adenocarcinoma through β-catenin/ID2 pathway. Mo SJ; Liu X; Hao XY; Chen W; Zhang KS; Cai JP; Lai JM; Liang LJ; Yin XY Cancer Lett; 2016 Oct; 380(2):403-412. PubMed ID: 27378242 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway. Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949 [TBL] [Abstract][Full Text] [Related]
20. TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling. Gou H; Liang JQ; Zhang L; Chen H; Zhang Y; Li R; Wang X; Ji J; Tong JH; To KF; Sung JJY; Chan FKL; Fang JY; Yu J Cancer Res; 2019 Jul; 79(13):3332-3346. PubMed ID: 31018940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]